Literature DB >> 2951046

Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.

G Sava, T Giraldi, L Perissin, S Zorzet, G Decorti.   

Abstract

The effects of cytotoxic (cyclophosphamide, CCNU, GANU), antiinvasive (vincristine, vinblastine) and antimetastatic (ICRF-159, DM-COOK) agents have been compared in mice-bearing P388 and L1210 leukemias, and TLX5 lymphoma. The drugs tested increase the survival time of the treated mice in a manner consistent with a cytotoxic action in the case of cyclophosphamide, CCNU, GANU, vincristine and vinblastine. Leukemic infiltration of the brain after i.p. tumor implantation has been determined by bioassay of this organ, and is reduced by treatment with all of the drugs tested, with the exception of ICRF-159. DM-COOK appears to increase the life-span of the treated animals by the inhibition of leukemic spread rather than by a cytotoxic action. The marked cytotoxicity of vincristine and vinblastine is sufficient to account for failure to detect any antimetastatic effects of these agents. The lack of antidisseminative effect observed for ICRF-159 under the experimental conditions employed might be connected with the observation that the antimetastatic action of this drug on solid tumors is due to its effects on tumor blood vessels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951046     DOI: 10.1007/bf00116623

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  16 in total

1.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Authors:  H E SKIPPER; F M SCHABEL; W S WILCOX
Journal:  Cancer Chemother Rep       Date:  1964-02

2.  Antimetastatic drugs: laboratory to clinic.

Authors:  K Hellmann
Journal:  Clin Exp Metastasis       Date:  1984 Jan-Mar       Impact factor: 5.150

3.  Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.

Authors:  T Giraldi; G Sava; R Cherubino; G Bottiroli; G Mazzini
Journal:  Clin Exp Metastasis       Date:  1984 Apr-Jun       Impact factor: 5.150

4.  Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.

Authors:  G Sava; T Giraldi; F Bartoli-Klugmann; G Decorti; F Mallardi
Journal:  Eur J Cancer Clin Oncol       Date:  1984-02

Review 5.  Selective antimetastatic drugs (review).

Authors:  T Giraldi; G Sava
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

6.  Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.

Authors:  G Sava; T Giraldi; L Lassiani; C Nisi
Journal:  Cancer Treat Rep       Date:  1982-09

Review 7.  Nitrosoureas: a review of experimental antitumor activity.

Authors:  F M Schabel
Journal:  Cancer Treat Rep       Date:  1976-06

8.  Invasiveness and tumorigenicity of MO4 mouse fibrosarcoma cells pretreated with microtubule inhibitors.

Authors:  C Meyvisch; G A Storme; E Bruyneel; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

9.  Effect of microtubule inhibitors on malignant invasion in vitro.

Authors:  M M Mareel; M J De Brabander
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

10.  Investigation of the in vivo anti-invasive and anti-metastatic effect of desacetyl vinblastine amide sulphate or vindesine.

Authors:  G Atassi; P Dumont; M Vandendris
Journal:  Invasion Metastasis       Date:  1982
View more
  2 in total

1.  Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Authors:  G Sava; S Zorzet; L Perissin; S Pacor; L Lassiani; C Nisi; A Varnavas
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat.

Authors:  T Klenner; F Wingen; B Keppler; P Valenzuela-Paz; F Amelung; D Schmähl
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.